Tyrosine hydroxylase inhibition in vitro and in vivo by chelating agents.
D000311:Adrenal Glands / Q000187:drug effects / Q000201:enzymology; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D002417:Cattle; D002614:Chelating Agents; D006321:Heart / Q000187:drug effects; D007501:Iron; D008297:Male; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D009206:Myocardium / Q000201:enzymology; D009638:Norepinephrine / Q000378:metabolism; D010618:Phenanthrolines / Q000494:pharmacology; D011621:Pteridines / Q000494:pharmacology; D011726:Pyridinium Compounds / Q000494:pharmacology; D051381:Rats; D014227:Triazines / Q000494:pharmacology; D014316:Tritium; D014443:Tyrosine
D002395:Catecholamines; D002614:Chelating Agents; D010618:Phenanthrolines; D011621:Pteridines; D011726:Pyridinium Compounds; D014227:Triazines; D014316:Tritium; D014443:Tyrosine; D007501:Iron; D006899:Mixed Function Oxygenases; D009638:Norepinephrine